文献速递重症综合管理与镇静镇痛

盲肠结扎穿孔改变糖皮质激素受体表达

Cecal Ligation and Puncture Alters Glucocorticoid Receptor Expression.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论小鼠盲肠结扎穿孔及脓毒症患者组织中糖皮质激素受体α减少、β增多,可能解释脓毒症时糖皮质激素反应性下降。

该研究在小鼠盲肠结扎穿孔模型及脓毒症死亡患者组织中检测糖皮质激素受体亚型丰度。基线及假手术小鼠结果一致;盲肠结扎穿孔后心脏、肺、骨骼肌中活化型受体α丰度降低,肝内αA、B、D亚型总和降低而αC不变,心脏和肺中失活型受体β丰度升高。盲肠结扎穿孔还降低心输出量及对地塞米松的心输出量反应,并降低葡萄糖-6-磷酸酶基因表达。与脓毒症患者相比,非脓毒症患者心脏和肝活检中α丰度较高、β丰度较低。

要点

  • 小鼠盲肠结扎穿孔后心脏、肺、骨骼肌中活化型糖皮质激素受体α丰度降低。
  • 盲肠结扎穿孔增加心脏和肺中失活型糖皮质激素受体β蛋白丰度。
  • 盲肠结扎穿孔降低心输出量并减弱地塞米松刺激后的心输出量反应。
  • 脓毒症患者心脏和肝组织中糖皮质激素受体α丰度低于非脓毒症患者,β丰度高于非脓毒症患者。
  • 受体α减少和β增多可能解释脓毒症时糖皮质激素反应性下降。

适用人群与场景

  • C57BL/6小鼠接受盲肠结扎穿孔或假手术。
  • 刚死于脓毒症或非脓毒症危重病患者的组织切片。

研究设计与关键结果

  • 研究类型为动物实验及人组织标本检测。
  • 基线及假手术小鼠结果一致;盲肠结扎穿孔后心脏、肺、骨骼肌中糖皮质激素受体αA丰度降低。
  • 肝脏中鉴定出所有糖皮质激素受体α亚型;盲肠结扎穿孔降低肝内α亚型总和及αA、B、D丰度,αC丰度不变。
  • 盲肠结扎穿孔增加心脏和肺中糖皮质激素受体β蛋白丰度。
  • 与T0相比,盲肠结扎穿孔降低心输出量并减弱地塞米松刺激后的心输出量反应。
  • 盲肠结扎穿孔降低葡萄糖-6-磷酸酶基因表达。
  • 与无脓毒症患者相比,脓毒症患者心脏和肝活检中糖皮质激素受体α丰度降低、β丰度升高。

证据类型、等级与局限

  • 证据类型:动物实验及人组织标本检测。
  • 统计显著性定义为p<0.05,采用方差分析。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Interventional trials on glucocorticoids in sepsis have yielded capricious results. Recent studies have identified multiple glucocorticoid receptor isoforms. The relative abundance of these isoforms in septic patients and following murine cecal ligation and puncture is unknown. The objective of this study is to determine the effects of cecal ligation and puncture on glucocorticoid receptor isoform abundance.

DESIGN: Determination of effects of cecal ligation and puncture on glucocorticoid receptor isoform subtype abundance in C57BL/6 mice. Examination of glucocorticoid receptor isoform abundance in tissues harvested from patients immediately after death from sepsis or nonseptic critical illness.

SETTING: Research laboratory.

SUBJECTS: C57BL/6 mice and human tissue sections from recently deceased critically ill patients.

INTERVENTIONS: C57BL/6 mice were subjected to cecal ligation and puncture or sham operation. Abundance of the activating glucocorticoid receptor α and the inactivating glucocorticoid receptor β isoforms was determined in mouse and human tissue using immunoblotting. Cardiac output with or without stimulation with dexamethasone was assessed using echocardiography. The expression of the gene encoding the glucocorticoid-dependent enzyme glucose-6-phosphatase was identified using polymerase chain reaction. Statistical significance (p < 0.05) was determined using analysis of variance.

MEASUREMENTS AND MAIN RESULTS: Results in baseline and sham operation mice were identical. At baseline, glucocorticoid receptor αA predominated in heart, lung, and skeletal muscle; abundance was decreased post cecal ligation and puncture. All glucocorticoid receptor α subtypes were identified in liver. Cecal ligation and puncture decreased the summed abundance of hepatic glucocorticoid receptor α subtypes and those of glucocorticoid receptors αA, B, and D. However, glucocorticoid receptor αC abundance was unchanged. Cecal ligation and puncture increased glucocorticoid receptor β protein abundance in the heart and lung. Relative to T0, cecal ligation and puncture decreased cardiac output and attenuated the cardiac output response to dexamethasone. Cecal ligation and puncture also decreased expression of glucose-6-phosphatase. Compared with nonseptic patients, human sepsis decreased the abundance of glucocorticoid receptor α and increased the abundance of glucocorticoid receptor β in heart and liver biopsies.

CONCLUSIONS: Cecal ligation and puncture altered glucocorticoid receptor α and glucocorticoid receptor β isoform expression in tissues and decreased functional responses in heart and liver. Decreases in glucocorticoid receptor α and increases in glucocorticoid receptor β might explain the diminished glucocorticoid responsiveness observed in sepsis.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Abraham MN, Jimenez DM, Fernandes TD, et al. Cecal Ligation and Puncture Alters Glucocorticoid Receptor Expression. Crit Care Med. 2018. PMID: 29787416. doi:10.1097/CCM.0000000000003201

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。